Picture of Optipharm Co logo

153710 Optipharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareBalancedMicro CapSucker Stock

Annual cashflow statement for Optipharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3,080-2,045-2,437-2,357-2,499
Depreciation
Amortisation
Non-Cash Items-1,181-1,32665.68481,207
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital1,215-184-785-701-1,936
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1,969-2,434-1,723-595-1,555
Capital Expenditures-757-4,604-1,737-1,736-2,545
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-6,6302,665-1,8522,7563,358
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-7,387-1,939-3,5891,020814
Financing Cash Flow Items-156-130-147-197-164
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1,8191,7601,993943-604
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-7,538-2,613-3,3191,367-1,345